Site Search

...  Additionally, advocates will educate the General Assembly on our goal of extending equitable and adequate access to Medicaid coverage for biomarker testing. In 2024, the legislature passed a bill to ensure more private insurance plans cover needed biomarker testing. Further action is needed to ensure Coloradans covered by Medicaid have similar access. “Victory in the fight against cancer ...

... patients, and caregivers are sharing this new data to help urge legislators to support a soon-to-be introduced bill to increase access to biomarker testing statewide.  Biomarker testing is often used to help connect a patient with the right treatment at the right time. After a cancer diagnosis, testing can help ...

... February 22, 2024 – A new paper released today in the Journal of Clinical Oncology    finds that while incorporating pharmacogenomic (PGx) testing into cancer care can help improve patient outcomes, barriers to PGx testing, discovery, and implementation are impacting its adoption and ... from them.” ACS CAN is working to improve access to PGx testing through its state advocacy work to expand insurance coverage of comprehensive biomarker testing, which includes PGx testing. Biomarker testing is a critical step toward accessing precision medicine, including targeted therapies; however, not all patients who could benefit ...

FRANKFORT, KY – Today, the General Assembly passed legislation that will increase access to biomarker testing, which can help determine the best treatment plan for a specific patient. Despite its benefits, private health insurance and Medicaid coverage of biomarker testing have not kept pace with the rate of innovation. This legislation, House Bill 180, fixes that barrier to access for many ...